Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PAAOX vs. IEUR: which is better?

Bottom line

PAAOX vs IEUR: the short answer

PAAOX (T. Rowe Price Asia Opportunities Fund) and IEUR (iShares Core MSCI Europe ETF) are both mutual funds.

IEUR is cheaper at 0.1% vs 1.25% — a difference of $115 a year per $10,000 invested.

Over five years, IEUR returned +4.8% a year vs +1.2% for PAAOX.

Updated Nov 19, 2026

PAAOX vs IEUR side by side

PAAOXIEUR
TypeMutual fundETF
Fund familyT. Rowe PriceiShares
CategorySingle Country / RegionSingle Country / Region
Expense ratio1.25%0.1%
Annual cost per $10k$125$10
10-yr cost on $10k (prospectus)$7,440$128
Max front load—None
12b-1 fee0.25%0%
1-yr return+11.3%+1.7%
5-yr return (annualized)+1.2%+4.8%
10-yr return (annualized)+5.7%+5.3%
Best quarter+21.0%+21.0%
Worst quarter−18.4%−25.2%
Net assets (fund)—$9.0B
Number of holdings—1,020
Portfolio turnover49%4%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

PAAOX and IEUR share none of their top holdings.

PAAOX top 10

    IEUR top 10

    1. ASML Holding N.V. — 4.00%
    2. Hsbc Holdings Plc — 2.29%
    3. Roche Holding AG — 1.92%
    4. Novartis AG — 1.79%
    5. Nestle S.A. — 1.61%
    6. Astrazeneca Plc — 1.61%
    7. Shell Plc — 1.60%
    8. Siemens Aktiengesellschaft — 1.52%
    9. Banco Santander, S.A. — 1.27%
    10. Sap Se — 1.20%

    FAQ

    What is the difference between PAAOX and IEUR?
    PAAOX (T. Rowe Price Asia Opportunities Fund) and IEUR (iShares Core MSCI Europe ETF) are both mutual funds. IEUR is cheaper at 0.1% vs 1.25% — a difference of $115 a year per $10,000 invested.
    Which is cheaper, PAAOX or IEUR?
    IEUR has the lower expense ratio (0.1%).
    Should I own both PAAOX and IEUR?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.